Therapy News and Research

RSS

Research explores pharmaceutical advances for IBS, hepatitis C

Research presented at Digestive Disease Week explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea and hepatitis C.

21 May 2013

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

21 May 2013

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain - that is, pain that arises from a malfunction in the nervous system.

21 May 2013

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.

20 May 2013

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

20 May 2013

Study shows people with SE-AN can be treated with outpatient treatment programme

Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.

20 May 2013

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics, Inc. today reported that Germany's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or three prior lines of therapy.

20 May 2013

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

20 May 2013

Targeting glucagon action: A new frontier for regulating diabetes

For the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

20 May 2013

Promising method to distinguish pancreatic cancer from chronic pancreatitis

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify almost all cases of pancreatic cancer, their study shows.

20 May 2013

New computational method may help track tumor progression, risk of relapse

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand.

20 May 2013

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.

20 May 2013

New colonoscope shows promise for colorectal cancer screening

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week.

20 May 2013

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22.

20 May 2013

Safety and efficacy evaluation methods for medical devices

Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device trail evaluations are much more complicated than drug trails due to their unique clinical practices.

18 May 2013

Enrollment now open for Nalanda Institute's Certificate Program in Contemplative Psychotherapy

The Nalanda Institute announced that enrollment is now open for their inaugural Certificate Program in Contemplative Psychotherapy to begin in Fall 2013. The program offers therapists, health workers, coaches, educators and other professionals in the healing arts an opportunity to immerse themselves in the inspiring new field of contemplative neuropsychology.

18 May 2013

EHRA EUROPACE 2013 to feature late breaking clinical trials

Attendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.

18 May 2013

AGA researchers to present exciting data on GI disorders at DDW 2013

Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week- 2013, the largest and most prestigious gastroenterology meeting, from May 18 to 21, 2013, at the Orange County Convention Center in Orlando, FL.

18 May 2013

Capella University's Marriage and Family Counseling/Therapy program gets COAMFTE accreditation

The Commission on Accreditation for Marriage and Family Therapy Education has accredited Capella University's Marriage and Family Counseling/Therapy program.

18 May 2013

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria.

18 May 2013

Therapy News and Research

Research explores pharmaceutical advances for IBS, hepatitis C

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Study shows people with SE-AN can be treated with outpatient treatment programme

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

Targeting glucagon action: A new frontier for regulating diabetes

Promising method to distinguish pancreatic cancer from chronic pancreatitis

New computational method may help track tumor progression, risk of relapse

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

New colonoscope shows promise for colorectal cancer screening

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Safety and efficacy evaluation methods for medical devices

Enrollment now open for Nalanda Institute's Certificate Program in Contemplative Psychotherapy

EHRA EUROPACE 2013 to feature late breaking clinical trials

AGA researchers to present exciting data on GI disorders at DDW 2013

Capella University's Marriage and Family Counseling/Therapy program gets COAMFTE accreditation

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News